Global Pseudofolliculitis Barbae Market, By Symptoms (Itching Pain, Darkening of the Skin, Small Papules, Pustules), Affected Area (Face, Underarms, Groin, Legs), Treatment (Hydrocortisone Cream, Topical Acne Treatments, Topical Corticosteroid, Hydroquinone, Oral Tetracyclines, Photodynamic Therapy, Others), End-User (Academic Institutes, Medical Research Centers, Clinics and Hospitals, Others) – Industry Trends and Forecast to 2030.
Pseudofolliculitis Barbae Market Analysis and Size
Pseudofolliculitis barbae (PFB) is a chronic inflammatory disorder of follicular and perifollicular skin characterized by papules, pustules, and post-inflammatory hyperpigmentation. It occurs more frequently in men of African and Asian descent. The etiology of PFB is multifactorial. Shaving or plucking the hair precipitates the onset of an inflammatory reaction that results from the penetration of the adjacent skin by the growing sharp tips. The curved shape of the hair follicle allows for the downward curvature and penetration of the growing hair tips into the skin.
Data Bridge Market Research analyses that the global pseudofolliculitis barbae market which was USD 184.12 million in 2022, is expected to reach USD 315.12 million by 2030, and is expected to undergo a CAGR of 5.5% during the forecast period of 2023 to 2030. “Itching Pain” dominates the symptoms segment of the global pseudofolliculitis barbae market due to high prevalence of pseudofolliculitis barbae. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Pseudofolliculitis Barbae Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Symptoms (Itching Pain, Darkening of the Skin, Small Papules, Pustules), Affected Area (Face, Underarms, Groin, Legs), Treatment (Hydrocortisone Cream, Topical Acne Treatments, Topical Corticosteroid, Hydroquinone, Oral Tetracyclines, Photodynamic Therapy , Others), End-User (Academic Institutes, Medical Research Centers, Clinics And Hospitals, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
GSK plc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Astrazeneca (U.S.), Pfizer Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Sanofi (U.S.), Amgen Inc. (U.S.), Daiichi Sankyo Company Limited (Japan), AB Sciences (France), Eisai Co., Ltd (Japan), Genentech Inc. (U.S), Merck & Co., Inc. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Pseudofolliculitis barbae can be defined as it encompasses all aspects related to the research, development, manufacturing, distribution, and utilization of skincare products, medical treatments, and dermatological procedures designed to address pseudofolliculitis barbae. PFB is characterized by the occurrence of inflamed, painful, and often itchy bumps in the beard area, particularly among individuals with curly hair. It is a common condition resulting from hair regrowth that curves back into the skin, causing inflammation and discomfort.
Global Pseudofolliculitis Barbae Market Dynamics
Drivers
- High Prevalence of Pseudofolliculitis Barbae
The prevalence of pseudofolliculitis barbae is significant, particularly among individuals with curly hair and those who engage in regular shaving practices. Factors such as hair type, hair regrowth patterns, and shaving techniques contribute to the widespread occurrence of PFB. The high prevalence drives the demand for effective treatments and skincare products.
- Advancements in Dermatological Research
Ongoing advancements in dermatological research have led to a better understanding of the underlying causes and mechanisms of pseudofolliculitis barbae. This knowledge has paved the way for the development of targeted and innovative therapies that address the specific pathways involved in PFB-related inflammation and ingrown hairs. Novel skincare products and medical treatments are being introduced with enhanced efficacy and reduced side effects, driving market growth.
- Patient-Centric Approach for Erythema
The PFB market offers a range of treatment modalities, including topical creams, gels, chemical exfoliants, laser therapies, and medical devices. The availability of diverse treatment options allows healthcare providers and dermatologists to tailor approaches to individual patient needs and preferences. Patients have the flexibility to choose treatments that align with their lifestyle and desired outcomes, contributing to market expansion.
Opportunities
- Telemedicine and Remote Monitoring
The integration of telemedicine and teledermatology services creates opportunities to expand access to PFB diagnosis and treatment. Healthcare providers can remotely assess patient’s PFB-related concerns, prescribe appropriate skincare products, and monitor treatment progress. Telemedicine supports patient education and follow-up, ensuring better adherence to treatment regimens.
- Personalized Medicine for Pseudofolliculitis Barbae
The concept of personalized medicine presents significant opportunities in the PFB market. Tailoring treatment plans to the specific needs and characteristics of individual patients can optimize therapeutic outcomes and minimize side effects. Advances in dermatogenetics and biomarker research enable the identification of patient-specific responses to PFB treatments, facilitating personalized care.
Restraints/Challenges
- Variable Treatment Outcomes for Pseudofolliculitis Barbae
The effectiveness of PFB treatments can vary among individuals, depending on factors such as skin type, hair type, and the severity of the condition. Achieving consistent and predictable treatment outcomes for all patients can be challenging. Healthcare providers and dermatologists must manage patient expectations and customize treatment plans accordingly.
- Regulatory Compliance and Safety
The development and approval of PFB products and treatments involve navigating complex regulatory processes and safety assessments. Regulatory hurdles, including clinical trial requirements, data submission, and post-market surveillance, can delay the introduction of new treatments to the market. Ensuring the safety and efficacy of PFB products is a paramount challenge for pharmaceutical companies and manufacturers.
This global pseudofolliculitis barbae market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global Pseudofolliculitis Barbae market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In January 2021, “National Rosacea Society”, reported that, 737,960,000 people affected with rosacea while the 420,280,000 people was diagnosed from rosacea. Also it reported that approximately 16 million Americans suffer from rosacea. Such trends are pushing more patients suffering from facial erythema to approach clinics and hospitals.
Global Pseudofolliculitis Barbae Market Scope
The global pseudofolliculitis barbae market is segmented on the basis of symptoms, affected area, treatment and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Symptoms
- Itching Pain
- Darkening of the Skin
- Small Papules
- Pustules
Affected Area
- Face
- Underarms
- Groin
- Legs
Treatment
- Hydrocortisone Cream
- Topical Acne Treatments
- Topical Corticosteroid
- Hydroquinone
- Oral Tetracyclines
- Photodynamic Therapy
- Others
End-User
- Academic Institutes
- Medical Research Centers
- Clinics
- Hospitals
- Others
Global Pseudofolliculitis Barbae Market Regional Analysis/Insights
The global pseudofolliculitis barbae market is analysed and market size insights and trends are provided by symptoms, affected area, treatment and end-user as referenced above.
The countries covered in the global pseudofolliculitis barbae market report are U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the global pseudofolliculitis barbae market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period of 2023 to 2030, due of the increase in the expenditure for research and development proficiencies, increasing government’s initiatives and improved health care infrastructure in various countries.
Asia-Pacific on the other hand is projected to exhibit the highest growth rate in the global pseudofolliculitis barbae market during the forecast period of 2023 to 2030 owing to the increasing government expenditure on healthcare sector and rising technological advancements and initiatives by the government.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global pseudofolliculitis barbae market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global pseudofolliculitis barbae market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global pseudofolliculitis barbae market. The data is available for historic period 2015 to 2020.
Competitive Landscape and Global Pseudofolliculitis Barbae Market Share Analysis
The global pseudofolliculitis barbae market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company's focus related to global pseudofolliculitis barbae market.
Some of the major players operating in the global pseudofolliculitis barbae market are:
- GSK plc. (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Novartis AG (Switzerland)
- Astrazeneca (U.S.)
- Pfizer Inc. (U.S.)
- Bristol-Myers Squibb Company (U.S.)
- Sanofi (U.S.)
- Amgen Inc. (U.S.)
- Daiichi Sankyo Company Limited (Japan)
- AB Sciences (France)
- Eisai Co., Ltd (Japan)
- Genentech Inc. (U.S)
- Merck & Co., Inc. (U.S.)
SKU-